Chemodex

N-Nitrosomethylphenylamine (NMPA)

CHF 90.00
In stock
CDX-N0372-G0011 gCHF 90.00
More Information
Product Details
Synonyms NMPA; N-Methyl-N-nitrosoaniline; N-Methyl-N-nitrosobenzenamine; N-Methyl-N-phenylnitrosamine; NSC137
Product Type Chemical
Properties
Formula C7H8N2O
MW 136.15
CAS 614-00-6
RTECS BY5775000
Source/Host Chemicals Synthetic
Purity Chemicals ≥98% (NMR)
Appearance Orange liquid.
Solubility Slightly soluble in DMSO, methanol, ethanol or chloroform.
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key MAXCWSIJKVASQC-UHFFFAOYSA-N
Smiles O=NN(C)C1=CC=CC=C1
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

N-nitrosomethylphenylamine (NMPA) is a nitrosamine and is known to be a potent carcinogen associated with cancer development in animals and humans. NMPA can damage DNA and cause mutations in genes that control cell growth and division. It reacts with DNA in vitro to form genotoxic activity, which may lead to cell death or mutagenesis. NMPA is formed in various industrial processes, including the synthesis of certain chemicals. It serves as a building block in the synthesis of diverse compounds and functions as an analytical reagent for environmental monitoring. This compound can be used as analytical reference material. NMPA is useful for studying enzymatic denitrosation processes. NMPA could be used as a tumor initiator, as a reagent for preparing carcinogenic animal diseases model.

Product References

(1) C.M. Goodall, et al.; Toxicol. Appl. Pharmacol. 17, 426 (1970) | (2) W. Lijinsky & R.M. Kovatch; Cancer Res. 48, 6648 (1988) | (3) S.R. Koepke, et al.; IARC Sci. Publ. 105, 346 (1991) | (4) T. Scheper, et al.; Chem. Biol. Interact. 77, 81 (1991) | (5) M. Stiborova, et al.; Cancer Lett. 110, 11 (1996) | (6) M. Stiborova, et al.; Cancer Lett. 138, 61 (1999) | (7) Y. Li & S.S. Hecht; Int. J. Mol. Sci. 23, 4559 (2022) | (8) M. Bignami, et al.; Efsa J. 21, e07884 (2023)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.